References
- Gardiner SJ, Begg EJ. Pharmacogenetics, drug-metabolizing enzymes, and clinical practice. Pharmacol Rev. 2006; 58(3): 521-590.
- Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics. 2004; 14(1): 1-18.
- Kimura S, Umeno M, Skoda RC, Meyer UA, Gonazalez FJ. The human debrisoquine 4-hydrolase(CYP2D)locus:Sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am J Hum Genet. 1989; 45(6): 889-904.
- The Human Cytochrome P450 (CYP) Allele Nomenclature committee. (http://www.cypalleles. ki.se/ cyp2d6.htm)
- Steen VM, Andreassen OA, Daly AK, Tefre T, Borresen A-L, Idle JR, et al. Detection of the poor metab-olizer-associated CYP2D6(D) gene deletion allele by long-PCR technology. Pharmacogenetics. 1995; 5(4): 215-223.
- Johansson I, Lundqvist E, Bertilsson L, Dahl ML, Sjoqvist F, Ingelman-Sundberg M. Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc Natl Acad Sci USA. 1993; 90(24): 11825-11829.
- The Pharmacogenomics Knowledge Base (PharmGKB) (https://www.pharmgkb.org/page/cpic).
- Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature. 2004; 429(6990): 464-468.
- Ma MK, Woo MH, McLeod HL. Genetic basis of drug metabolism. Am J Health Syst Pharm. 2002; 59(21): 2061-2069.
- Ingelman-Sundberg M, Oscarson M, McLellan RA. Polymorphic human cytochrome P450 enzymes: An opportunity for individualized drug treatment. Trends Pharmacol Sci. 1999; 20(8): 342-349.
- Meyer UA. Pharmacogenetics – five decades of therapeutic lessons from genetic diversity. Nat Rev Genet. 2004; 5(9): 669-676.
- Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics. 2002; 3(2): 229-243.
- Tateishi T, Chida M, Ariyoshi N, Mizorogi Y, Kamataki T, Kobayashi S. Analysis of the CYP2D6 gene in relation to dextromethorphan Odemethylation capacity in a Japanese population. Clin Pharmacol Ther. 1999; 65(5): 570-575.
- Gaedigk A, Gotschall RR, Forbes NS, Simon SD, Kearns GL, Leeder JS. Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. Phar-macogenetics. 1999; 9(6): 669-682.
- Sistonen J, Sajantila A, Lao O, Corander J, Barbujani G, Fuselli S. CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet Genomics. 2007; 17(2): 93-101.
- Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): Clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J. 2004; 5(1): 6-13.
- Soderback E, Zackrisson AL, Lindblom B, Alderborn A. Determination of CYP2D6 gene copy number by pyrosequencing. Clin Chem. 2005; 51(3): 522-531.
- Lundqvist E, Johansson I, Ingelman-Sundberg M. Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes. Gene. 1999; 226(2): 327-338
- Lindpaintner K. Pharmacogenetics and the future of medical practice. Br J Clin Pharmacol. 2002; 54(2): 221-230.
- Kirchheiner J, Nickchen K, Bauer M, Wong ML, Licinio J, Roots I, et al. Pharmacogenetics of antidepressants and antipsychotics: The contribution of allelic variations to the phenotype of drug response (Review). Mol Psychiatry. 2004; 9(5): 442-473.
- Sistonen J, Fuselli S, Levo A, Sajantila A. CYP 2D6 genotyping by a multiplex primer extension reaction. Clin Chem. 2005; 51(7): 1291-1295.
- Goddard KA, Hopkins PJ, Hall JM, Witte JS. Linkage disequilibrium and allele-frequency distributions for 114 single-nucleotide polymerphisms in five populations. Am J Hum Genet. 2000; 66(1): 216-234.
- Rebsamen MC, Desmeules J, Daali Y, Chiappe A, Diemand A, Rey C, et al. The AmpliChip CYP450 test: Cytochrome P450 2D6 genotype assessment and phenotype prediction. Pharmacogenomics J. 2009; 9(1): 34-41.
- Umamaheswaran G, Dhakchinamoorthi K, Chan-drasekaran A. Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters – a review with Indian perspective. Indian J Med Res. 2014; 139(1): 27-65.
- Al-Dosari M, Al-Jenoobi F, Alkharfy K, Alghamdi A, Bagulb K, Parvez M, et al. High prevalence of CYP 2D6*41 (G2988A) allele in Saudi Arabians. Environ Toxicol Pharmacol. 2013; 36(3): 1063-1067. 10.1016/j. etap.2013.09.008.
- Qumsieh RY, Ali BR, Abdulrazzaq YM, Osman O, Akawi NA, Bastaki SMA. Identification of new alleles and the determination of alleles and genotypes frequencies at the CYP2D6 gene in Emiratis. PLoS ONE. 2011; 6(12): e28943. 10.1371/journal.pone.0028943.
- Kapedanovska NestorovskaA, Jakovski K, Naumovska Z, Hiljadnikova Bajro M, Sterjev Z, Eftimov A, et al. Distribution of the most common genetic variants associated with a variable drug response in the population of the Republic of Macedonia. Balkan J Med Genet. 2014; 17(2): 5-14. 10.2478/bjmg-2014-0069
- Chou WH1, Yan FX, de Leon J, Barnhill J, Rogers T, Cronin M, et al. Extension of a pilot study: Impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness. J Clin Psychopharmacol. 2000; 20(2): 246-251.
- Bozina N, Granić P, Lalić Z, Tramisak I, Lovrić M, Stavljenić-Rukavina A. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population. Croat Med J. 2003; 44(4): 425-428.
- Arvanitidis K, Ragia G, Iordanidou M, Kyriaki S, Xanthi A, Tavridou A, et al. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population. Fundam Clin Pharmacol. 2007; 21(4): 419-426.
- Buzková H, Pechandová K, Slanar O, Perlik F. Frequency of single nucleotide polymorphisms of CYP-2D6 in the Czech population. Cell Biochem Funct. 2008; 26(1): 76-81.
- Sachse C, Brockmoller J, Bauer S, Roots I. Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences. Am J Hum Genet. 1997; 60(2): 284-295.